CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Impact of Drug Adherence of Tyrosine Kinase Inhibitors in Children with Ph-Positive Acute Lymphoblastic Leukemia

Jun-Xia Wang, Miao-Miao Yang, Li-Peng Liu, Hui-Min Zhang, Meng-Chuan Wang, Yu-Wen Chen, Xiao-Ying Zang, Fang Hu

Cancer Research and Treatment. 2023;55(3):1023-1030. Published online 2023 February 6 DOI: https://doi.org/10.4143/crt.2022.1618

Clinical Impact of Drug Adherence of Tyrosine Kinase Inhibitors in Children with Ph-Positive Acute Lymphoblastic Leukemia

Jun-Xia Wang, Miao-Miao Yang, Li-Peng Liu, Hui-Min Zhang, Meng-Chuan Wang, Yu-Wen Chen, Xiao-Ying Zang, Fang Hu

Cancer Research and Treatment. 2023;55(3):1023-1030

Link1

Link2 Link3

Managing Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitors

Farhad Ravandi

Clinical Lymphoma Myeloma and Leukemia. 2011;11(2):198-203

Link1 Link2

The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Yuanfeng Zhang, Sizhou Feng

Leukemia Research. 2021;109:106647

Link1 Link2

Second-Generation Tyrosine Kinase Inhibitors Can Induce Complete Molecular Response in Ph-Positive Acute Lymphoblastic Leukemia After Allogeneic Stem Cell Transplant

Carmen Fava, Giovanna Rege-Cambrin, Alessandro Busca, Enrico Gottardi, Filomena Daraio, Giuseppe Saglio

Clinical Lymphoma Myeloma and Leukemia. 2013;13:S272-S275

Link1 Link2

ALL-022 Assessment of Molecular Response to Tyrosine Kinase Inhibitors in Tunisian Patients With Ph+ Acute Lymphoblastic Leukemia

Rim Frikha, Amina El Aoud, Hassen Kamoun

Clinical Lymphoma Myeloma and Leukemia. 2023;23:S237

Link1 Link2

POSTER: ALL-022 Assessment of Molecular Response to Tyrosine Kinase Inhibitors in Tunisian Patients With Ph+ Acute Lymphoblastic Leukemia

Rim Frikha, Amina El Aoud, Hassen Kamoun

Clinical Lymphoma Myeloma and Leukemia. 2023;23:S149

Link1 Link2

Tyrosine Kinase Inhibitors and Reduced-Dose Chemotherapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

chunping wu, mengting zeng, yuanzhong chen, yong wu

. 2021;

Link1 Link2

Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia

Fang-yuan Zheng, Ai-dong Lu, Ying-xi Zuo, Yue-ping Jia, Jun Wu, Le-ping Zhang

Leukemia Research. 2020;95:106405

Link1 Link2

Survival Impact of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome Positive (Ph+) de novo Acute Myeloid Leukemia (AML)

Onyee Chan, Seongseok Yun, Anna Halpern, Hani Babiker, Srinath Sundararajan, Jorge Ramos, Paul Hendrie, Utkarsh Acharya

Clinical Lymphoma Myeloma and Leukemia. 2017;17:S296-S297

Link1 Link2

ABL-specific tyrosine kinase inhibitor, STI571 in vitro, affects Ph-positive acute lymphoblastic leukemia and chronic myelogenous leukemia in blastic crisis

A Nakajima, T Tauchi, K Ohyashiki

Leukemia. 2001;15(6):989-990

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.